ADVERTISEMENT

market

The Auto Injectors Market is Expected to Grow at a CAGR of 16.60%, 2022-2030

ADVERTISEMENT

Growth Plus Report

PUNE, Nov. 24, 2022 (GLOBE NEWSWIRE) — According to a new market research report, “auto injector market By Product Type (Disposable Auto-Injector, Reusable Auto-Injector), By Disease Indication (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Others) and By End User (Hospital, Home Care, Others) – Global Outlook and Forecasts 2022-2030″ Published by Growth Plus Reports, auto-injector market is expected to grow CAGR of 16.60% to be reached in 2021 $191.21 billion by 2030.

Download sample PDF brochure auto injector market,

request/request-sample/auto-injector-market/7925

market driver

Increasing demand for targeted therapies and self-administration is the key driver for the global auto-injector market. Moreover, the increasing incidence of anaphylaxis, migraine and chronic diseases such as diabetes, rheumatoid arthritis and multiple sclerosis is also a major driver of the global auto-injector market. Autoinjectors have many benefits, including better dose quality and efficacy, reduced needle phobia, fewer needle stick injuries and accidents, and greater dosing accuracy. Increase in biologics research and development as well as growing adoption of biologics and biosimilars are facilitating the growth of the auto-injector market. The use of advanced technologies, the expiration of biological patents and increased investment by industry leaders to produce affordable and reusable injectors are expected to drive the market growth.

The global auto-injector market has been analyzed from three perspectives: product type, disease indication, end user, and region.

Fraction FROM ‘By product type Segmentation’

Based on the product type, the global auto-injector market has been segmented

  • disposable

  • reusable auto injector

Disposable auto-injectors account for the largest market share in 2021. The large share of disposable auto-injectors is mainly attributed to ease of use. They have a built-in syringe, eliminating manual loading of the syringe and increasing the safety of the device. Biopharmaceutical companies are investing in advanced technologies to improve single-use auto-injectors. For example, in March 2022, Ipsen announced plans to invest in new state-of-the-art electronic autoinjectors for Somatuline, AutoGel/Somatuline Depot (lanreotide), to bring additional innovation to the classroom to improve the administration and injection experience for patients. explain. This device will be made in collaboration with Philips-Medisize.

Also read  US Equities - Wall St poised to open flat as focus shifts to Powell speech

The story continues

Excerpt from ‘Signs of Disease by Segmentation’

Based on disease indications, the global auto-injector market has been segmented

  • Rheumatoid arthritis

  • multiple sclerosis

  • diabetes mellitus

  • anaphylaxis

  • other treatments

Anaphylaxis segment is expected to dominate the market with the largest market share by 2021. Diabetes is another major application area for autoinjectors. The segment is growing due to the increasing demand for insulin auto-injectors. According to the International Diabetes Federation, type 1 diabetes affects about 10% of the diabetic population, affecting about 1.2 million children and adolescents. In addition, the demand for self-insulin in home care is also driving growth in the segment.

Excerpts from ‘Per Area Division’

On the basis of region, the global auto-injector market is classified into

  • North America

  • Europe

  • Asia Pacific

  • the rest of the world

North America will dominate the global auto-injector market in 2021. Europe has the second largest auto-injector market. Most of the market can be attributed to the rising prevalence of anaphylaxis and chronic diseases such as diabetes, rheumatoid arthritis and multiple sclerosis. According to the European Academy of Allergy and Clinical Immunology (EAACI), more than 150 million people in Europe suffer from chronic allergic conditions. In the UK, about 20% of the population has allergies. According to the MRC Asthma UK Center on Allergic Mechanisms of Asthma, allergies cause about 20 in 30 deaths in the UK.

Excerpts from ‘Competitive Landscape’

Some of the major players in the global auto-injector market are

  • mylan nv

  • ABV Inc.

  • Eli Lilly and Co

  • Amgen Inc.

  • Becton, Dickinson & Company

  • Ypsomed Holding AG

  • Johnson & Johnson

  • Teva Pharmaceutical Industries Limited

  • Pfizer Inc.

  • Merck Kaga

  • Owen Mumford

  • Halozyme Therapeutics

  • GlaxoSmithKline plc

  • Biogen Inc.

  • Sanofi SA

  • Scandinavian Health Ltd

Also read  First big hit in the Tybee Island corporate vacation market

Before purchasing this research report, please inquire:

check/before buy/auto-injector-market/7925

table of contents

  1. introduction

    1. market ecosystem

    2. Pending timeline

      1. Historical year – 2020

      2. Base year – 2021

      3. Projected years – 2022 to 2030

    3. reporting currency

  2. research method

    1. research approach

    2. data collection method

    3. data source

      1. secondary source

      2. primary sources

    4. approach to market estimates

      1. from bottom to top

      2. top to bottom

    5. market prediction model

    6. Limitations and Assumptions

  3. premium insight

    1. Current Market Trends (COVID-19 Perspective)

    2. Key players and competitive position (2021)

  4. market dynamics

    1. the drivers

    2. Limitations/Challenges

    3. opportunity

  5. Global Auto Injector Market – Analysis and Forecast by Product Type

    1. Disposable auto-injector

    2. reusable auto injector

      1. preloaded

      2. empty

  6. Global Autoinjector Market – Analysis and Forecast, by Disease Indication

    1. Rheumatoid arthritis

    2. multiple sclerosis

    3. diabetes mellitus

    4. anaphylaxis

    5. other treatments

  7. Global Auto Injector Market – Analysis & Forecast, By End Users

    1. Hopital

    2. home care

    3. Other (Ambulatory Surgical Center, Day Care, etc.)

TOC issued…

Report scope:

report attribute

Description

Market size value in 2021

48 billion dollars

Sales forecast in 2030

US$191.21 billion

growth rate

CAGR of 16.60% from 2022 to 2030

base year for assessment

2021

forecast period

2022-2030

segments covered

Product type, disease indication, end user and region.

regional reach

North America, Europe, Asia Pacific and Rest of the World (ROW)

Report Related Value Proposition:

  • Powered with free analyst hours and expert interviews with every report

  • Extensive quantitative and qualitative insights at segment and sub-segment level

  • covid 19 impact trends and perspective

  • Detailed insights at global/regional/country level

  • Deeper understanding of market dynamics (drivers, constraints, opportunities) and business environment

  • General coverage of the competitive landscape

  • win the imperative

  • Extensive reporting on ‘Strategic Developments’ recorded by the major players in the market

Also read  The rental market is cooling in Phoenix, but rent affordability is still an issue for some

Customization options,

  • Distributor Landscape Assessment

  • Pipeline evaluation

  • pricing information

  • estimate of the customer base

  • Analysis of investments and initiatives

  • ‘Company profile’ of key players

Quickly buy a premium copy of auto injector market Report:

checkout?_token=6Xf4OeYdDWa1ST0hqICMhoa5w0EwLgoboL1z8BOz&report_id=7925&license=single

about us

Growth Plus Reports is part of GRG Health, a global healthcare knowledge services company. We are a proud member of the EPhMRA (European Pharmaceutical Marketing Research Association).

Growth+’s portfolio of services draws on our core capabilities of secondary and primary research, market modeling and forecasting, benchmarking, analysis and strategy formulation to help clients build scalable, breakthrough solutions that position them for future growth and prepare them for success.

We were awarded as the “Most Innovative Healthcare Market Research Company in 2020” by the prestigious CEO Magazine.

Contact: Manan Sethi Director, Market Insights Email: [email protected] Phone number: +91 96545 76783 Internet:

Source: news.google.com

ADVERTISEMENT

ADVERTISEMENT

Leave a Comment